Zoom Meeting (Information posted at the end of the announcement)
Rare-Earth Nanoparticles for Non-invasive In Vivo Imaging of Immune Cells
in Cancer Immunotherapy
Cancer immunotherapy is fast emerging as a promising treatment approach for many cancers. However, outcomes remain highly variable across individuals, as only a minority of patients respond, and addressing this variability is one of the most active areas of immunotherapy research. Studies have shown that the infiltration of tumors by immune cell subtypes is one of the most significant prognostic indicators of disease-free survival across a large number of cancers. However, we remain limited in our ability to non-invasively sample the continuously evolving tumor micro-environment for the presence of immune cells that can give us critical insights into the response status of the patient.
Rare-earth nanoparticles are an exciting new class of optical materials very attractive for high resolution imaging of deep tissue structures. They have narrow and tunable emission bands in regions of near-zero tissue autofluorescence (1300-1700nm), large anti-Stokes shift enabling clear separation of excitation and emission wavelengths, high photostability for continuous and repetitive imaging, and very low intrinsic toxicity in vivo due to their exceptional chemical inertness, making them attractive for clinical translation. Moreover, near-infrared optical imaging technology offers several advantages over conventional clinical imaging tools in terms of resolution, cost, safety, and repeatability.
In this thesis, we show for the first time that near-infrared imaging using rare-earth nanoparticles can serve as a powerful tool to non-invasively image the distribution of immune cells in a tumor. We first present nanoparticle synthesis strategies for the generation of small but ultra-bright rare earth nanocrystals necessary for deep tissue imaging of rare cell types. We then evaluate a variety of surface modification approaches and present new methods for facile and reproducible phase-transfer of these nanoparticles for further biofunctionalization. Finally, we demonstrate that these nanoparticles can be used for high resolution in vivo imaging of tumor-infiltrating T-cells in a melanoma tumor model. The ability to noninvasively monitor the immune contexture of a tumor during immunotherapy will yield valuable real time insights into the response status of a patient, and could lead to early identification of responding and non-responding patient cohorts.
Thesis Supervisor:
Angela M. Belcher, PhD
James Mason Crafts Professor of Biological Engineering and Materials Science and Engineering, MIT
Thesis Committee Chair:
Darrell J. Irvine, PhD
Professor of Materials Science & Engineering and Biological Engineering, MIT
Thesis Reader:
Paula T. Hammond, PhD
Institute Professor, David H. Koch (1962) Professor of Engineering, MIT
------------------------------------------------------------------------------------------------------
Zoom invitation -
Swati Kataria is inviting you to a scheduled Zoom meeting.
Topic: Swati Kataria Thesis Defense
Time: Friday, May 21, 2021 9:00 AM Eastern Time (US and Canada)
Your participation is important to us: please notify hst [at] mit.edu, at least 3 business days in advance, if you require accommodations in order to access this event.
Join Zoom Meeting
https://mit.zoom.us/j/93830636741
Password: 807256
One tap mobile
+16465588656,,93830636741# US (New York)
+16699006833,,93830636741# US (San Jose)
Meeting ID: 938 3063 6741
US : +1 646 558 8656 or +1 669 900 6833
International Numbers: https://mit.zoom.us/u/adSkYUF5zY
Join by SIP
93830636741 [at] zoomcrc.com (93830636741[at]zoomcrc[dot]com)
Join by Skype for Business
https://mit.zoom.us/skype/93830636741